Document Detail

Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
MedLine Citation:
PMID:  6605748     Owner:  NLM     Status:  MEDLINE    
The effects of two types of synthetic inhibitor of fibrinolytic enzymes (omega-aminocarboxylic acids, benzamidine derivatives) on intravascular fibrinolysis and fibrinogenolysis were studied in rats. Generalised primary fibrinogenolysis was produced by infusion of human plasminogen-streptokinase complex, secondary fibrinolysis was induced by infusion of the thrombin-like enzyme batroxobin. The inhibitors exerted different effects on the hyperfibrinolytic states. The omega-aminocarboxylic acids (PAMBA, AMCA) inhibited fibrinolysis more effective than fibrinogenolysis. In contrast, the benzamidines (APPA, NANP) were more potent inhibitors of fibrinogenolysis. Aprotinin examined for comparison behaved like the benzamidine derivatives.
F Markwardt; H P Klöcking
Related Documents :
24482778 - Ascorbic acid for the safe use of a sunscreen agent: accumulation of nano zinc oxide an...
10608808 - The epithelial na(+)/h(+) exchanger, nhe3, is internalized through a clathrin-mediated ...
6429268 - Five doubly unsaturated metabolites of valproic acid in urine and plasma of patients on...
1756428 - Pattern- and age-dependency of the antiepileptic effects induced by valproic acid in th...
17252188 - Lipid-based nanoparticles for nucleic acid delivery.
10995028 - Amino acid sequence of the protease inhibitor bwi-4a from buckwheat seeds.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Biomedica biochimica acta     Volume:  42     ISSN:  0232-766X     ISO Abbreviation:  Biomed. Biochim. Acta     Publication Date:  1983  
Date Detail:
Created Date:  1983-12-20     Completed Date:  1983-12-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8304435     Medline TA:  Biomed Biochim Acta     Country:  GERMANY, EAST    
Other Details:
Languages:  eng     Pagination:  725-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
4-Aminobenzoic Acid / analogs & derivatives,  pharmacology*
Amidines / pharmacology*
Aminobenzoic Acids / pharmacology*
Antifibrinolytic Agents / pharmacology*
Batroxobin / pharmacology
Benzamidines / pharmacology*
Cyclohexanecarboxylic Acids / pharmacology*
Fibrinogen / metabolism*
Fibrinolysis / drug effects*
Structure-Activity Relationship
Thrombin / metabolism
Tranexamic Acid / pharmacology*
Reg. No./Substance:
0/Amidines; 0/Aminobenzoic Acids; 0/Antifibrinolytic Agents; 0/Benzamidines; 0/Cyclohexanecarboxylic Acids; 1197-18-8/Tranexamic Acid; 150-13-0/4-Aminobenzoic Acid; 56-91-7/4-aminomethylbenzoic acid; 9001-32-5/Fibrinogen; EC 3.4.21.-/Batroxobin; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Selective binding of peanut lectin by T lineage lymphocytes in paraffin sections.
Next Document:  Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin-2...